133 related articles for article (PubMed ID: 29982583)
1. Hydrocortisone Affects Fatigue and Physical Functioning Through Metabolism of Tryptophan: A Randomized Controlled Trial.
Sorgdrager FJH; Werumeus Buning J; Bos EH; Van Beek AP; Kema IP
J Clin Endocrinol Metab; 2018 Sep; 103(9):3411-3419. PubMed ID: 29982583
[TBL] [Abstract][Full Text] [Related]
2. Hydrocortisone Dose Influences Pain, Depressive Symptoms and Perceived Health in Adrenal Insufficiency: A Randomized Controlled Trial.
Werumeus Buning J; Brummelman P; Koerts J; Dullaart RP; van den Berg G; van der Klauw MM; Sluiter WJ; Tucha O; Wolffenbuttel BH; van Beek AP
Neuroendocrinology; 2016; 103(6):771-8. PubMed ID: 26646751
[TBL] [Abstract][Full Text] [Related]
3. The effects of two different doses of hydrocortisone on cognition in patients with secondary adrenal insufficiency--results from a randomized controlled trial.
Werumeus Buning J; Brummelman P; Koerts J; Dullaart RP; van den Berg G; van der Klauw MM; Tucha O; Wolffenbuttel BH; van Beek AP
Psychoneuroendocrinology; 2015 May; 55():36-47. PubMed ID: 25705800
[TBL] [Abstract][Full Text] [Related]
4. Tryptophan and Kynurenine Levels and Its Association With Sleep, Nonphysical Fatigue, and Depression in Chronic Hemodialysis Patients.
Malhotra R; Persic V; Zhang W; Brown J; Tao X; Rosales L; Thijssen S; Finkelstein FO; Unruh ML; Ikizler A; Garimella PS; Ix JH; Kooman J; Levin NW; Handelman GJ; Kotanko P
J Ren Nutr; 2017 Jul; 27(4):260-266. PubMed ID: 28366444
[TBL] [Abstract][Full Text] [Related]
5. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
[TBL] [Abstract][Full Text] [Related]
6. Somatosensory function in patients with secondary adrenal insufficiency treated with two different doses of hydrocortisone-Results from a randomized controlled trial.
Werumeus Buning J; Konopka KH; Brummelman P; Koerts J; Dullaart RPF; van den Berg G; van der Klauw MM; Tucha O; Wolffenbuttel BHR; van Beek AP
PLoS One; 2017; 12(7):e0180326. PubMed ID: 28686664
[TBL] [Abstract][Full Text] [Related]
7. [Impact of interferon alpha immunotherapy on tryptophan metabolism in patients with chronic hepatitis C. Results of a pilot studies on ten patients].
Vignau J; Costisella O; Canva V; Imbenotte M; Duhamel A; Lhermitte M
Encephale; 2009 Oct; 35(5):477-83. PubMed ID: 19853722
[TBL] [Abstract][Full Text] [Related]
8. Effects of Hydrocortisone on the Regulation of Blood Pressure: Results From a Randomized Controlled Trial.
Werumeus Buning J; van Faassen M; Brummelman P; Dullaart RP; van den Berg G; van der Klauw MM; Kerstens MN; Stegeman CA; Muller Kobold AC; Kema IP; Wolffenbuttel BH; van Beek AP
J Clin Endocrinol Metab; 2016 Oct; 101(10):3691-3699. PubMed ID: 27490921
[TBL] [Abstract][Full Text] [Related]
9. Obesity-related dysregulation of the tryptophan-kynurenine metabolism: role of age and parameters of the metabolic syndrome.
Mangge H; Summers KL; Meinitzer A; Zelzer S; Almer G; Prassl R; Schnedl WJ; Reininghaus E; Paulmichl K; Weghuber D; Fuchs D
Obesity (Silver Spring); 2014 Jan; 22(1):195-201. PubMed ID: 23625535
[TBL] [Abstract][Full Text] [Related]
10. Influence of hydrocortisone dosage scheme on health-related quality of life in patients with adrenal insufficiency.
Bleicken B; Hahner S; Loeffler M; Ventz M; Decker O; Allolio B; Quinkler M
Clin Endocrinol (Oxf); 2010 Mar; 72(3):297-304. PubMed ID: 19508599
[TBL] [Abstract][Full Text] [Related]
11. The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls.
Sorgdrager FJH; Doornbos B; Penninx BWJH; de Jonge P; Kema IP
J Affect Disord; 2017 Nov; 222():32-39. PubMed ID: 28668713
[TBL] [Abstract][Full Text] [Related]
12. Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder.
Mukherjee D; Krishnamurthy VB; Millett CE; Reider A; Can A; Groer M; Fuchs D; Postolache TT; Saunders EFH
Bipolar Disord; 2018 Feb; 20(1):27-34. PubMed ID: 28833866
[TBL] [Abstract][Full Text] [Related]
13. Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: relationship with oxidative stress improvement.
Zinellu A; Sotgia S; Mangoni AA; Sanna M; Satta AE; Carru C
Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):153-9. PubMed ID: 25534866
[TBL] [Abstract][Full Text] [Related]
14. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder.
Birner A; Platzer M; Bengesser SA; Dalkner N; Fellendorf FT; Queissner R; Pilz R; Rauch P; Maget A; Hamm C; Herzog-Eberhard S; Mangge H; Fuchs D; Moll N; Zelzer S; Schütze G; Schwarz M; Reininghaus B; Kapfhammer HP; Reininghaus EZ
PLoS One; 2017; 12(2):e0172699. PubMed ID: 28241062
[TBL] [Abstract][Full Text] [Related]
15. The tryptophan/kynurenine pathway, systemic inflammation, and long-term outcome after kidney transplantation.
de Vries LV; Minović I; Franssen CFM; van Faassen M; Sanders JS; Berger SP; Navis G; Kema IP; Bakker SJL
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F475-F486. PubMed ID: 28490533
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of oral hydrocortisone - Results and implications from a randomized controlled trial.
Werumeus Buning J; Touw DJ; Brummelman P; Dullaart RPF; van den Berg G; van der Klauw MM; Kamp J; Wolffenbuttel BHR; van Beek AP
Metabolism; 2017 Jun; 71():7-16. PubMed ID: 28521880
[TBL] [Abstract][Full Text] [Related]
17. Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency.
Quinkler M; Miodini Nilsen R; Zopf K; Ventz M; Øksnes M
Eur J Endocrinol; 2015 May; 172(5):619-26. PubMed ID: 25656494
[TBL] [Abstract][Full Text] [Related]
18. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.
Johannsson G; Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Olsson T; Ragnarsson O; Ryberg M; Wahlberg J; Biller BM; Monson JP; Stewart PM; Lennernäs H; Skrtic S
J Clin Endocrinol Metab; 2012 Feb; 97(2):473-81. PubMed ID: 22112807
[TBL] [Abstract][Full Text] [Related]
19. Tryptophan metabolism in post-withdrawal alcohol-dependent patients.
Gleissenthall GV; Geisler S; Malik P; Kemmler G; Benicke H; Fuchs D; Mechtcheriakov S
Alcohol Alcohol; 2014; 49(3):251-5. PubMed ID: 24644258
[TBL] [Abstract][Full Text] [Related]
20. Kynurenine pathway changes in late-life depression.
Wu Y; Zhong X; Mai N; Wen Y; Shang D; Hu L; Chen B; Zhang M; Ning Y
J Affect Disord; 2018 Aug; 235():76-81. PubMed ID: 29655078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
